• Episode #14: The advantages of team-based care for hypertension and a bonus segment on CCB-related lower extremity edema
    Jan 1 2025

    Listen in as Anthony Ishak, PharmD talks about the advantages of team-based care for hypertension. Then, in a bonus segment, Dr. Molly Brett joins us to discuss a paper she covered for the New England Journal of Medicine Journal Watch on the adverse events associated with prescribing diuretics after calcium-channel blockers.

    Show More Show Less
    32 mins
  • Episode #13: Dr. Yvonne Commodore-Mensah on local and global interventions to improve BP control in persons of African descent
    Jun 27 2024

    Listen in as we learn from our guest speaker, Dr. Yvonne Commodore-Mensah, about her "glocal" work exploring healthy equity issues in hypertension prevention and management for people of African descent both in Ghana and in the United States.


    Show More Show Less
    32 mins
  • Episode #12: Dr. Anika Hines on race-related stress and social determinants of health
    Jun 12 2023

    Join us as we learn from our guest speaker, Dr. Anika Hines, about her fascinating research on structural racism, interpersonal racism and social determinants of health. In particular, we will explore how these things impact cardiovascular health and hear about her work on ways we can holistically address stress, improve health and empower patients.

    Show More Show Less
    35 mins
  • Episode #11: A recap of the ACCORD trial
    Apr 12 2023

    Listen in for a review of the ACCORD BP trial, another episode in our series of podcasts devoted to discussing the landmark trials that have informed care and guidelines for the care of patients with hypertension. The ACCORD (Action to Control Cardiovascular Risk in Diabetes) BP trial explored whether intensive BP control (<120 mmHg) reduced rates of nonfatal MI, nonfatal stroke or CV mortality when compared with standard (<140 mmHg) blood pressure targets. Spoiler alert: it's complicated!!

    Show More Show Less
    17 mins
  • Episode #10: Dr. Jordana Cohen on the evaluation of primary aldosteronism
    Mar 10 2023

    Join us as we welcome Dr. Jordana Cohen, a nephrologist and a hypertension specialist at UPenn for a discussion about why (and how!) we should be looking for more primary aldosteronism in our patients with hypertension.

    Show More Show Less
    34 mins
  • Episode #9: A recap of the HYVET trial
    Dec 22 2022

    Listen in for a review and discussion of HYVET (HYpertension in the Very Elderly Trial), a landmark trial in the field of hypertension research that began the fundamental shift in how we consider blood pressure thresholds for our older patients.

    Show More Show Less
    16 mins
  • Episode #8: An overview of ARBs and ACE inhibitors
    Oct 4 2022

    Join us and learn from Anthony Ishak, our clinical pharmacist, who provides an overview of the nuances of different ARBs and ACE inhibitors in hypertension treatment.

    Show More Show Less
    23 mins
  • Episode #7: Prevalence of medications that may raise blood pressure among adults with hypertension in the United States
    Sep 1 2022

    Many may not be aware that medications, both prescription and over the counter, can RAISE your blood pressure. Join us to learn from special guest, Tim Anderson, as he describes his recent publication in JAMA IM that details which medications may be the culprits and how often patients with hypertension are taking them.

    Show More Show Less
    16 mins